February 27, 2017
Recommended Topic Related To:

Caprelsa

"Vemurafenib (Zelboraf, Roche/Genentech), a BRAF inhibitor marketed for use in the treatment of melanoma, has now shown activity in patients with refractory papillary thyroid cancer.

For the approximately 25% to 50% of patients "...

A A A

Caprelsa

Overdosage
Contraindications

OVERDOSE

In the event of an overdose, monitor patients closely for QTc prolongation. Because of the 19-day halflife, adverse reactions may not resolve quickly.

CONTRAINDICATIONS

Do not use in patients with congenital long QT syndrome [see BOX WARNING].

This monograph has been modified to include the generic and brand name in many instances.

Last reviewed on RxList: 12/5/2016

Overdosage
Contraindications

Additional Caprelsa Information

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Women's Health

Find out what women really need.